{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for amphotericin root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
NCT03287908: Phase 1 Interventional Terminated Relapsed/Refractory Multiple Myeloma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03486067: Phase 1 Interventional Active, not recruiting Multiple Myeloma
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ispectamab debotansine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04450407: Phase 2 Interventional Completed Type 1 Diabetes Mellitus
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03695185: Phase 2 Interventional Completed Ulcerative Colitis (UC)
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03849651: Phase 2 Interventional Active, not recruiting Acute Lymphoblastic Leukemia (ALL)
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03060538: Phase 1 Interventional Completed Diabetes Mellitus, Type 2
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04477772: Phase 1 Interventional Completed Recurrent/Refractory Malignant Lymphoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
